Factors affecting growth and antibiotic susceptibility of : effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant Free

Abstract

This study investigated how pH and the presence of urea affect the survival and growth of and whether these factors affect susceptibility to antibiotics The viability of a wild-type strain and a urease-deficient mutant of was studied after incubation for 1 h in buffers at different pH values at 37°C under microaerophilic conditions. Viable counts were not affected at pH 5 and pH 7. In buffer at pH 3, there were no viable organisms, but urea (6.25 m) protected the wild-type strain, which survived well. At pH 9, urea further reduced the viability of and flurofamide almost abolished the effect of urea on the wild-type strain. Neither urea nor flurofamide affected the viability of the urease-deficient mutant under the same conditions. Growth was also pH dependent and was enhanced in shake-cultures. At pH 5, urea supported growth of the wild-type strain, but at pH 7 a toxic effect on the bacteria was observed. Growth of at pH 5.9 was poor, and susceptibility to amoxycillin, erythromycin and clarithromycin was markedly less than at pH 7.2 and 7.9. The bactericidal activities of metronidazole and tetracycline were similar at the different pH values studied. At neutral pH the killing rates of amoxycillin and clarithromycin were growth rate dependent. Susceptibility to metronidazole was enhanced in stationary cultures. The interaction obtained between the proton pump inhibitor, omeprazole, and amoxycillin at pH 7 was of additive type. These results suggest that pH and growth conditions may be important in the antibacterial efficacy of different antibiotics and also provide a possible explanation for the potentiating effect of omeprazole with antibiotics in the treatment of infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-6-425
1996-06-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/6/medmicro-44-6-425.html?itemId=/content/journal/jmm/10.1099/00222615-44-6-425&mimeType=html&fmt=ahah

References

  1. Graham D. Y. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991; 6:105–113
    [Google Scholar]
  2. Graham D. Y., Malaty H. M., Evans D. G., Evans D. J., Klein P. D., Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 1991; 100:1495–1501
    [Google Scholar]
  3. Marshall B. J., Barrett J. L., Prakash C., McCallum R. W., Guerrant R. L. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 1990; 99:697–702
    [Google Scholar]
  4. Goodwin C. S., Collin M. D., Blincow E. The absence of thermoplasmaquinones in Campylobacter pyloridis, and its temperature and pH growth range. Microbios Letters 1986; 32:137–140
    [Google Scholar]
  5. Goodwin C. S., Armstrong J. A. Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbiol Infect Dis 1990; 9:1–13
    [Google Scholar]
  6. Morgan D. R., Freedman R., Depew C. E., Kraft W. G. Growth of Campylobacter pylori in liquid media. J Clin Microbiol 1987; 25:2123–2125
    [Google Scholar]
  7. Kangatharalingam N., Amy P. S. Helicobacter pylori comb. nov. exhibits facultative acidophilism and obligate microaerophilism. Appl Environ Microbiol 1994; 60:2176–2179
    [Google Scholar]
  8. Greig M. A., Neithercut W. D., Hossack M., McColl K. E. L. Harnessing of urease activity of Helicobacter pylori to induce self-destruction of the bacterium. J Clin Pathol 1991; 44:157–159
    [Google Scholar]
  9. Eaton K. A., Brooks C. L., Morgan D. R., Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 1991; 59:2470–2475
    [Google Scholar]
  10. Ferrero R. L., Lee A. The importance of urease in acid protection for the gastric-colonising bacteria, Helicobacter pylori and Helicobacter felis sp. nov. Microb Ecol Health Dis 1991; 4:121–134
    [Google Scholar]
  11. Mobley H. L., Hausinger R. P. Microbial ureases: significance, regulation, and molecular characterization. Microbiol Rev 1989; 53:85–108
    [Google Scholar]
  12. Engel E., Peskoff A., Kauffman G. L., Grossman M. I. Analysis of hydrogen ion concentration in the gastric gel mucus layer. Am J Physiol 1984; 247:G321–338
    [Google Scholar]
  13. Flemström G., Gamer A. Gastroduodenal HCO 3 transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 1982; 242:G183–193
    [Google Scholar]
  14. Glupczynski Y. In vitro susceptibility testing of Helicobacter pylori to antimicrobial agents: basis for treatment of microbiologists’ obsession?. Zentralbl Bakteriol 1993; 280:227–238
    [Google Scholar]
  15. Glupczynski Y., Burette A., Labbe M., Deprez C., De Reuck M., Deltenre M. Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol 1988; 83:365–372
    [Google Scholar]
  16. Hirschl A. M., Hentschel E., Schiitze K. The efficacy of antimicrobial treatment in Campylobacter pylori-associated gastritis and duodenal ulcer. Scand J Gastroenterol 1988; 23: Suppl 14276–81
    [Google Scholar]
  17. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. J. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94:33–40
    [Google Scholar]
  18. Chiba N., Rademaker J. W., Rao B. V., Hunt R. H. Eradication of Helicobacter pylori pylori-meta-analysis to determine optimal therapy. Gut 1991; 32:A1220–A1221
    [Google Scholar]
  19. Tytgat G. N. J., Axon A. T. R., Dixon M. F., Graham D. Y., Lee A., Marshall B. J. World Congresses of Gastroenterology. Working Party Reports 36–45 Melbourne, Australia: Blackwell Scientific Publications;
    [Google Scholar]
  20. Graham D. Y., Lew G. M., Malaty H. M Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102:493–496
    [Google Scholar]
  21. Pavicic M. J., Namavar F., Verboom T., van Winkelhoff A. J., De Graaff J. In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations. Antimicrob Agents Chemother 1993; 37:1184–1186
    [Google Scholar]
  22. van Caekenberghe D. L., Breyssens J. In vitro synergistic activity between bismuth subcitrate and various antimicrobial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother 1987; 31:1429–1430
    [Google Scholar]
  23. Grayson M. L., Eliopoulos G. M., Ferraro M. J., Moellering R. C. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989; 8:888–889
    [Google Scholar]
  24. Malanoski G. J., Eliopoulos G. M., Ferraro M. J., Moellering R. C. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin. Eur J Clin Microbiol Infect Dis 1993; 12:131–133
    [Google Scholar]
  25. McNulty C. A. M. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In Rathbone B. J., Heatley R. V. (eds) Campylobacter pylori and gastroduodenal disease Oxford: Blackwell Scientific Publications; 1989209–216
    [Google Scholar]
  26. Unge P., Gad A., Gnarpe H., Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol 1989; 24: Suppl 16749–54
    [Google Scholar]
  27. Bazzoli F., Zagari R. M., Fossi P. Short-term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6:773–777
    [Google Scholar]
  28. Lind T., Veldhuyzen van Zanten S. J. O., Unge P. The MACH 1 study: optimal one-week treatment for H. pylori defined?. Gut 1995; 37: Suppl 1A4
    [Google Scholar]
  29. Millar M. R., Pike J. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori. Antimicrob Agents Chemother 1992; 36:185–187
    [Google Scholar]
  30. Mégraud F., Trimoulet P., Lamouliatte H., Boyanova L. Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob Agents Chemother 1991; 35:869–872
    [Google Scholar]
  31. Ferrero R. L., Cussac V., Courcoux P., Labigne A. Construction of isogenic urease-negative mutants of Helicobacter pylori by allelic exchange. J Bacteriol 1992; 174:4212–4217
    [Google Scholar]
  32. Miles A. A., Misra S. S., Irwin J. O. The estimation of the bactericidal power of the blood. J Hyg 1938; 38:732–748
    [Google Scholar]
  33. Krogstad D. J., Moellering R. C. Antimicrobial combinations. In Lorian V. (ed) Antibiotics in laboratory medicine 2nd edn Baltimore: The Williams and Wilkins Co; 1986537–595
    [Google Scholar]
  34. Dick J. D. A new twist to an old disease. Annu Rev Microbiol 1990; 44:249–269
    [Google Scholar]
  35. Goodwin C. S., Armstrong J. A., Marshall B. J. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986; 39:353–365
    [Google Scholar]
  36. Neithercut W. D., Greig M. A., Hossack M., McColl K. E. L. Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia. J Clin Pathol 1991; 44:380–384
    [Google Scholar]
  37. Coudron P. E., Kirby D. F. Comparison of rapid urease test, staining techniques, and growth on different solid media for detection of Campylobacter pylori. J Clin Microbiol 1989; 27:1527–1530
    [Google Scholar]
  38. Shahamat M., Mai U. E. H., Paszko-Kolva C., Yamamoto H., Colwell R. R. Evalution of liquid media for growth of Helicobacter pylori. J Clin Microbiol 1991; 29:2835–2837
    [Google Scholar]
  39. Barry A. L., Jones R. N., Thomsberry C. In vitro activities of Azithromycin (CP 62,993), Clarithromycin (A-56268; TE-031), Erythromycin, Roxithromycin, and Clindamycin. Antimicrob Agents Chemother 1988; 32:752–754
    [Google Scholar]
  40. Logan R. P. H., Gummett P. A., Hegarty B. T., Walker M. M., Baron J. H., Misiewicz J. J. Clarithromycin and omeprazole for Helicobacter pylori. Lancet 1992; 340:239
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-44-6-425
Loading
/content/journal/jmm/10.1099/00222615-44-6-425
Loading

Data & Media loading...

Most cited Most Cited RSS feed